Prevail InfoWorks
Prevail InfoWorks is a clinical research technology company specializing in integrated data analytics and trial management platforms for the pharmaceutical and biotech industries.
Profile
Provides a unified platform for managing and analyzing clinical trial data across pharmaceutical and biotech research.
Prevail InfoWorks is a clinical research technology company specializing in integrated data analytics and trial management platforms for the pharmaceutical and biotech industries. Founded over 15 years ago, the company has built a reputation for its Single Interface® platform, which consolidates clinical trial data from disparate sources into a unified analytics environment. The system is designed to improve data quality, accelerate trial timelines, and reduce costs by providing real-time insights into safety and efficacy signals.
Prevail's platform has been used in hundreds of studies across major therapeutic areas, including oncology, neurology, and infectious diseases, and has supported FDA-approved drug applications. The company differentiates itself through its ability to integrate diverse data sources and deliver complex analytics without breaking trial blinding. Recent developments include the FDA's pilot program for real-time clinical trial data review, which aligns with Prevail's capabilities. While financial specifics are not publicly disclosed, the company's focus on AI-driven clinical trial innovations positions it in a growing niche as the industry shifts toward more automated and data-driven drug development processes.
Who buys this
- Pharmaceutical companies conducting clinical trials
- Biotechnology firms developing new therapies
- Contract research organizations (CROs) managing trials for sponsors
- Academic medical centers running investigator-initiated studies
- Regulatory consultants preparing submissions for health authorities
Strengths and what to watch
Strengths
- 15+ years of validated platform use in FDA-approved drug applications
- Comprehensive data integration from EDC, pharmacovigilance, and trial management systems
- Real-time analytics capability without unblinding clinical trials
Watch for
- Increasing competition from larger clinical trial software vendors expanding into analytics
- Regulatory scrutiny around AI use in clinical data interpretation
- Client concentration risk with reliance on pharma/biotech R&D budgets
Recent moves
Key Information
- Founded
- 2005
- Headquarters
- Philadelphia, PA
Frequently Asked Questions
What is Prevail InfoWorks?
Prevail InfoWorks provides a unified platform for managing and analyzing clinical trial data, serving pharmaceutical and biotech researchers. Their Single Interface® system integrates disparate data sources, offering real-time analytics while maintaining trial blinding. Used in hundreds of studies, it supports FDA-approved drug applications across therapeutic areas.
How does Prevail's platform help with FDA compliance?
The platform aligns with FDA's real-time data review pilot programs, providing validated analytics without compromising trial blinding. It consolidates electronic data capture, pharmacovigilance, and trial management systems into auditable workflows, supporting regulatory submissions with 15+ years of proven use in approved drug applications.
What makes Prevail different from other clinical trial software?
Prevail specializes in integrating diverse data sources while preventing unblinding, a critical FDA requirement. Their AI-driven analytics deliver real-time insights without breaking trial protocols, unlike generic platforms. The system's oncology, neurology, and infectious disease applications are proven in hundreds of studies.
Can Prevail's platform handle real-time clinical trial monitoring?
Yes, the Single Interface® platform provides real-time analytics across integrated data sources, enabling sponsors to detect safety or efficacy signals immediately. This capability supports the FDA's 2026 initiative for accelerated trial reviews while maintaining strict data blinding protocols required in late-phase studies.
Which therapeutic areas does Prevail's platform support?
The platform has validated applications in oncology, neurology, and infectious disease trials, covering small molecules to biologics. Its flexible architecture adapts to therapeutic-specific endpoints, adverse event monitoring, and biomarker analyses while maintaining compliance with therapeutic-area-specific regulatory requirements.
How does AI enhance Prevail's clinical trial analytics?
AI automates data integration from disparate trial systems, identifying patterns without human intervention that could risk unblinding. The technology prioritizes safety signals and efficacy trends, reducing manual review time. Prevail participates in industry explorations of AI's role in accelerating 2026-era drug development timelines.
Sources
- prevailinfoworks.com — Recent company news and product capabilities
- prevailinfoworks.com — Product details and company differentiation
- www.informationweek.com — Industry context on tech/AI impacts in 2025-2026
- techcrunch.com — Market trends in AI adoption affecting clinical tech